M H Qazilbash
Overview
Explore the profile of M H Qazilbash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qazilbash M, Wieder E, Thall P, Wang X, Rios R, Lu S, et al.
Leukemia
. 2016 Sep;
31(3):697-704.
PMID: 27654852
PR1, an HLA-A2-restricted peptide derived from both proteinase 3 and neutrophil elastase, is recognized on myeloid leukemia cells by cytotoxic T lymphocytes (CTLs) that preferentially kill leukemia and contribute to...
2.
Varma A, Saliba R, Torres H, Afrough A, Hosing C, Khouri I, et al.
Bone Marrow Transplant
. 2016 Mar;
51(7):999-1001.
PMID: 26950376
No abstract available.
3.
Shah J, Feng L, Thomas S, Berkova Z, Weber D, Wang M, et al.
Blood Cancer J
. 2016 Feb;
6:e396.
PMID: 26871714
The safety and efficacy of siltuximab (CNTO 328) was tested in combination with lenalidomide, bortezomib and dexamethasone (RVD) in patients with newly-diagnosed, previously untreated symptomatic multiple myeloma. Fourteen patients were...
4.
Cornelison A, Saliba R, Afrough A, Dinh Y, Nieto Y, Bashir Q, et al.
Bone Marrow Transplant
. 2015 Oct;
51(2):307-9.
PMID: 26479980
No abstract available.
5.
Kongtim P, Qazilbash M, Shah J, Hamdi A, Shah N, Bashir Q, et al.
Bone Marrow Transplant
. 2015 Mar;
50(5):668-72.
PMID: 25730192
Cardiac involvement in light-chain amyloidosis (AL) predicts poor prognosis and is associated with higher TRM and morbidity during high-dose therapy and auto-SCT (HDT-ASCT). We studied the outcomes of 30 patients...
6.
Shah N, Thall P, Fox P, Bashir Q, Shah J, Parmar S, et al.
Leukemia
. 2015 Feb;
29(9):1945-8.
PMID: 25721897
No abstract available.
7.
The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma
Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H, et al.
Br J Cancer
. 2014 Jun;
111(3):628-36.
PMID: 24921909
Background: Insulin/insulin-like growth factor-1 signalling may underlie the promoting effect of type 2 diabetes on cancer. This study examined the association of diabetes, including steroid-induced diabetes (SID), and the impact...
8.
Parmar S, Kongtim P, Champlin R, Dinh Y, Elgharably Y, Wang M, et al.
Bone Marrow Transplant
. 2014 Jun;
49(8):1036-41.
PMID: 24887378
Optimal treatment approach continues to remain a challenge for systemic light chain amyloidosis (AL). So far, Auto-SCT is the only modality associated with long-term survival. However, failure to show survival...
9.
Patel K, Nusrat M, Shah N, Bashir Q, Parmar S, Shah J, et al.
Bone Marrow Transplant
. 2014 Jan;
49(3):465-6.
PMID: 24419515
No abstract available.
10.
Yilmaz M, Chemaly R, Han X, Thall P, Fox P, Tarrand J, et al.
Bone Marrow Transplant
. 2013 Mar;
48(9):1218-23.
PMID: 23503529
Disseminated adenoviral infection (AI) is associated with profound immunosuppression and poor outcome after allogeneic hematopoietic SCT (allo-HSCT). A better understanding of AI in allo-HSCT recipients can serve as a basis...